Skip to main content

Vera Therapeutics, Inc.

VERA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001831828

In the last 90 days, Vera Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 219 institutions reported holding it in 13F filings for Q2 2026, worth $3.34B in total; no superinvestor holds it.

13F holders, Q2 2022

Institutional positions in Vera Therapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
51
+2 vs. Q1 2022
Shares held
20.4M
+721.9K (+3.7%) vs. Q1 2022
Total value
$277.6M
−$191.3M (−40.8%) vs. Q1 2022
New holders
6
20 more added
Sold out
4
11 more reduced

1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting VERA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2022: 51 institutions
Q1 2021: 0 institutionsQ2 2021: 22 institutionsQ3 2021: 31 institutionsQ4 2021: 37 institutionsQ1 2022: 50 institutionsQ2 2022: 51 institutionsQ3 2022: 55 institutionsQ4 2022: 59 institutionsQ1 2023: 70 institutionsQ2 2023: 76 institutionsQ3 2023: 84 institutionsQ4 2023: 95 institutionsQ1 2024: 159 institutionsQ2 2024: 171 institutionsQ3 2024: 173 institutionsQ4 2024: 178 institutionsQ1 2025: 179 institutionsQ2 2025: 172 institutionsQ3 2025: 176 institutionsQ4 2025: 214 institutionsQ1 2026: 229 institutionsQ2 2026: 219 institutions
Value heldQ2 2022: $277.6M
Q1 2021: $0Q2 2021: $186.1MQ3 2021: $252.4MQ4 2021: $374.9MQ1 2022: $468.9MQ2 2022: $277.6MQ3 2022: $459.0MQ4 2022: $412.8MQ1 2023: $289.7MQ2 2023: $611.9MQ3 2023: $538.2MQ4 2023: $637.2MQ1 2024: $2.21BQ2 2024: $1.92BQ3 2024: $2.37BQ4 2024: $2.66BQ1 2025: $1.52BQ2 2025: $1.51BQ3 2025: $1.89BQ4 2025: $3.75BQ1 2026: $2.92BQ2 2026: $3.34B
Institutions holding VERA and their total value by quarter
QuarterHoldersValue
Q2 2026219$3.34B
Q1 2026229$2.92B
Q4 2025214$3.75B
Q3 2025176$1.89B
Q2 2025172$1.51B
Q1 2025179$1.52B
Q4 2024178$2.66B
Q3 2024173$2.37B
Q2 2024171$1.92B
Q1 2024159$2.21B
Q4 202395$637.2M
Q3 202384$538.2M
Q2 202376$611.9M
Q1 202370$289.7M
Q4 202259$412.8M
Q3 202255$459.0M
Q2 202251$277.6M
Q1 202250$468.9M
Q4 202137$374.9M
Q3 202131$252.4M
Q2 202122$186.1M
Q1 20210$0

Institutions, Q2 2022

Shares, value and share of portfolio for each institution holding Vera Therapeutics, Inc.; share changes are against Q1 2022.

Institutions holding VERA in Q2 2022
InstitutionSharesValue% of portfolioChange in sharesAction
FMR LLC4,015,351$54.6M0.01%+3,321+0.1%Added
Sofinnova Investments, Inc.3,181,442$43.3M3.85%00.0%Unchanged
Abingworth LLP2,960,231$40.3M12.90%00.0%Unchanged
Citadel Advisors LLC2,122,851$28.9M0.04%+33,331+1.6%Added
Ra Capital Management, L.P.1,578,820$21.5M0.57%−387,264−19.7%Reduced
Kynam Capital Management, LP1,522,712$20.7M5.35%+1,020,384+203.1%Added
BlackRock Inc.717,034$9.76M0.00%+37,359+5.5%Added
Vanguard Group Inc676,937$9.21M0.00%+58,934+9.5%Added
Vivo Capital, LLC666,666$9.07M0.91%00.0%Unchanged
Octagon Capital Advisors LP575,000$7.83M2.09%00.0%Unchanged
Baker Bros. Advisors LP333,333$4.54M0.03%00.0%Unchanged
Alphabet Inc.301,580$4.11M0.22%00.0%Unchanged
Polar Asset Management Partners Inc.294,300$4.00M0.05%+234,300+390.5%Added
Millennium Management LLC276,243$3.76M0.00%+142,743+106.9%Added
State Street Corp222,255$3.02M0.00%+53,498+31.7%Added
Geode Capital Management, LLC204,588$2.78M0.00%+2,041+1.0%Added
Northern Trust Corp112,470$1.53M0.00%+3,063+2.8%Added
Bank of Montreal96,849$1.41M0.00%+96,849New
JPMorgan Chase & Co98,936$1.35M0.00%−50,665−33.9%Reduced
Bank of New York Mellon Corp75,084$1.02M0.00%+26,248+53.7%Added
Nuveen Asset Management, LLC74,322$1.01M0.00%+20,699+38.6%Added
Charles Schwab Investment Management Inc34,691$473.0K0.00%−52−0.1%Reduced
Swiss National Bank34,700$472.0K0.00%+34,700New
Bank of America Corp21,454$292.0K0.00%+5,850+37.5%Added
California State Teachers Retirement System18,554$253.0K0.00%+12,704+217.2%Added
Raymond James Financial Services Advisors, Inc.17,828$243.0K0.00%00.0%Unchanged
Rhumbline Advisers16,272$221.0K0.00%+5,887+56.7%Added
Carnegie Mellon University16,060$219.0K0.11%00.0%Unchanged
Alps Advisors Inc16,060$219.0K0.00%+16,060New
Ensign Peak Advisors, Inc13,277$181.0K0.00%00.0%Unchanged
Dynamic Technology Lab Private Ltd11,939$162.0K0.02%+11,939New
Citigroup Inc11,230$153.0K0.00%+335+3.1%Added
New York State Common Retirement Fund10,982$149.0K0.00%−10.0%Reduced
Cambridge Trust Co9,887$135.0K0.01%00.0%Unchanged
Credit Suisse AG9,604$131.0K0.00%+9,604New
MetLife Investment Management8,881$120.9K0.00%00.0%Unchanged
Deutsche Bank AG8,573$116.0K0.00%+469+5.8%Added
American International Group, Inc.6,488$88.0K0.00%−306−4.5%Reduced
Legal & General Group Plc4,898$67.0K0.00%+3,591+274.8%Added
Morgan Stanley3,465$47.0K0.00%−15,053−81.3%Reduced
Amalgamated Bank2,157$29.0K0.00%+719+50.0%Added
STRS Ohio1,600$21.0K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)1,430$19.0K0.00%+1,203+530.0%Added
Metropolitan Life Insurance Co1,041$14.2K0.00%00.0%Unchanged
Ameritas Investment Partners, Inc.1,061$14.0K0.00%00.0%Unchanged
Barclays PLC696$9.00K0.00%−1,526−68.7%Reduced
Royal Bank of Canada578$8.00K0.00%−763−56.9%Reduced
Wells Fargo & Company343$5.00K0.00%−2,612−88.4%Reduced
UBS Group AG395$5.00K0.00%−1,614−80.3%Reduced
State of Wyoming28$00.00%+28New
International Biotechnology Trust PLC3,825––−186,924−98.0%Reduced
Logos Global Management LP0$00.00%−385,000−100.0%Sold out
Maven Securities LTD0$00.00%−64,240−100.0%Sold out
Gyon Technologies Capital Management, LP0$00.00%−16,961−100.0%Sold out
US Bancorp0$00.00%−1,000−100.0%Sold out
Amalgamated Financial Corp.––––Not filed